Diabetes stigma is associated with negative treatment appraisals among adults with insulin-treated Type 2 diabetes: results from the second Diabetes MILES - Australia (MILES-2) survey

被引:35
作者
Holmes-Truscott, E. [1 ,2 ]
Browne, J. L. [1 ,2 ]
Ventura, A. D. [1 ,2 ]
Pouwer, F. [3 ]
Speight, J. [1 ,2 ,4 ]
机构
[1] Deakin Univ, Sch Psychol, Geelong, Vic, Australia
[2] Diabet Victoria, Australian Ctr Behav Res Diabet, Melbourne, Vic, Australia
[3] Univ Southern Denmark, Dept Psychol, Odense, Denmark
[4] AHP Res, Hornchurch, England
关键词
SOCIAL STIGMA; SELF-MANAGEMENT; THERAPY; EXPERIENCES; ADHERENCE; ATTITUDES; IMPACT; SCALE; CARE;
D O I
10.1111/dme.13598
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AimTo explore factors associated with negative insulin appraisals among adults with Type 2 diabetes, including perceived and experienced diabetes stigma. MethodsThe second Diabetes MILES - Australia study (MILES-2) is a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 456 adults with insulin-treated Type 2 diabetes (38% women; mean sd age: 61.2 8.8 years; diabetes duration: 14.5 7.5 years; years using insulin: 6.4 5.5). Participants completed validated measures of perceived and experienced diabetes stigma (Type 2 Diabetes Stigma Assessment Scale), insulin appraisals [Insulin Treatment Appraisal Scale (ITAS)] and known correlates of insulin appraisals: diabetes-specific distress (Problem Areas In Diabetes scale) and diabetes-specific self-efficacy (Confidence in Diabetes Self-care scale). A multiple linear regression was conducted (N = 279) to determine the contribution of those variables found to be associated with ITAS Negative scores. ResultsUnivariable analyses revealed negative insulin appraisals were associated with demographic and self-care characteristics (age, employment status, BMI, years using insulin, injections per day), self-efficacy, diabetes-specific distress and diabetes stigma (all P < 0.01). Number of injections per day [regression coefficient [95% confidence interval]: 0.74 [0.08, 1.40]; P = 0.028], self-efficacy [-0.12 [-0.19, -0.06]; P < 0.001] and diabetes stigma [0.39 (0.31, 0.46); P < 0.001) significantly and independently contributed to the final multivariable model, explaining 58% of the variance in ITAS Negative scores. The independent contribution of diabetes-specific distress was suppressed following the inclusion of diabetes stigma. ConclusionsThis study represents the first step in understanding the relationship between perceived and experienced diabetes stigma and negative insulin appraisals, and provides quantitative evidence for the strong, independent relationship between these two important constructs.
引用
收藏
页码:658 / 662
页数:5
相关论文
共 20 条
  • [1] Cohort profiles of the cross-sectional and prospective participant groups in the second Diabetes MILES-Australia(MILES-2) study
    Browne, Jessica L.
    Holmes-Truscott, Elizabeth
    Ventura, Adriana D.
    Hendrieckx, Christel
    Pouwer, Frans
    Speight, Jane
    [J]. BMJ OPEN, 2017, 7 (02):
  • [2] Measuring the Stigma Surrounding Type 2 Diabetes: Development and Validation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2)
    Browne, Jessica L.
    Ventura, Adriana D.
    Mosely, Kylie
    Speight, Jane
    [J]. DIABETES CARE, 2016, 39 (12) : 2141 - 2148
  • [3] 'I'm not a druggie, I'm just a diabetic': a qualitative study of stigma from the perspective of adults with type 1 diabetes
    Browne, Jessica L.
    Ventura, Adriana
    Mosely, Kylie
    Speight, Jane
    [J]. BMJ OPEN, 2014, 4 (07):
  • [4] 'I call it the blame and shame disease': a qualitative study about perceptions of social stigma surrounding type 2 diabetes
    Browne, Jessica L.
    Ventura, Adriana
    Mosely, Kylie
    Speight, Jane
    [J]. BMJ OPEN, 2013, 3 (11):
  • [5] Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
    Davies, M. J.
    Gagliardino, J. J.
    Gray, L. J.
    Khunti, K.
    Mohan, V.
    Hughes, R.
    [J]. DIABETIC MEDICINE, 2013, 30 (05) : 512 - 524
  • [6] Negative appraisals of insulin therapy are common among adults with Type 2 diabetes using insulin: Results from Diabetes MILES - Australia cross-sectional survey
    Holmes-Truscott, E.
    Skinner, T. C.
    Pouwer, F.
    Speight, J.
    [J]. DIABETIC MEDICINE, 2015, 32 (10) : 1297 - 1303
  • [7] The impact of insulin therapy and attitudes towards insulin intensification among adults with type 2 diabetes: A qualitative study
    Holmes-Truscott, Elizabeth
    Browne, Jessica L.
    Speight, Jane
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (06) : 1151 - 1157
  • [8] Further investigation of the psychometric properties of the insulin treatment appraisal scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from diabetes MILES - Australia
    Holmes-Truscott, Elizabeth
    Pouwer, Frans
    Speight, Jane
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [9] Participants' experiences of intensifying insulin therapy during the Treating to Target in Type 2 Diabetes (4-T) trial: qualitative interview study
    Jenkins, N.
    Hallowell, N.
    Farmer, A. J.
    Holman, R. R.
    Lawton, J.
    [J]. DIABETIC MEDICINE, 2011, 28 (05) : 543 - 548
  • [10] Flexible eating and flexible insulin dosing in patients with diabetes: Results of an intensive self-management course
    Lowe, J.
    Linjawi, S.
    Mensch, M.
    James, K.
    Attia, J.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 80 (03) : 439 - 443